Human Papillomavirus Vaccine: A New Opportunity for the Treatment of Human Papillomavirus Infections

Sneha Ambwani; Prabhu Prakash; Seema Surana; Suman Bhansali

首页> 外文期刊>National Journal of Community Medicine >Human Papillomavirus Vaccine: A New Opportunity for the Treatment of Human Papillomavirus Infections

【24h】

Human Papillomavirus Vaccine: A New Opportunity for the Treatment of Human Papillomavirus Infections

机译：人乳头瘤病毒疫苗：治疗人乳头瘤病毒感染的新机会

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The current article discuss the use of Human Papillomavirus Vaccine as an Opportunity for the Treatment of Human Papillomavirus Infections.

机译：本文讨论了人乳头瘤病毒疫苗作为治疗人乳头瘤病毒感染的机会。

著录项

来源
《National Journal of Community Medicine》 |2014年第2期|共2页
作者
Sneha Ambwani; Prabhu Prakash; Seema Surana; Suman Bhansali;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma. [J] . Agrawal Y, Koch WM, Xiao W, Clinical cancer research: an official journal of the American Association for Cancer Research . 2008,第21期

机译：人乳头瘤病毒16阳性和人乳头瘤病毒16阴性的头颈部鳞状细胞癌治疗前后的口服人乳头瘤病毒感染。
2. Correction: Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-na???ˉve women: results from the control arm of a phase II HPV-16/18 vaccine trial,Incidence and duration of type-specific human papillomavirus infection in [J] . BMJ Open . 2016,第9期

机译：更正：高危HPV初生女性中特定类型的人乳头瘤病毒感染的发生率和持续时间：II期HPV-16 / 18疫苗试验的对照组的结果，特定类型的人的发生率和持续时间乳头瘤病毒感染
3. Human papillomavirus 16-positive uterine cervical squamous cell carcinoma with coinfection with human papillomavirus 34 has a lower incidence in lymph node metastasis than that without coinfection with human papillomavirus 34 [J] . MichimataR., WatariH., TomaruU., Pathobiology: journal of immunopathology, molecular and cellular biology . 2013,第5期

机译：人乳头瘤病毒16阳性并合并人乳头瘤病毒34的子宫宫颈鳞状细胞癌的淋巴结转移发生率低于未人乳头瘤病毒34并发的情况
4. Proteomic identification of head and neck cancer patients with persistent human papillomavirus infections associated with improved survival [C] . Nicolas Schlecht, Nicole Kawachi, Yanhua Wang, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：持续人乳头瘤病毒感染的头颈癌患者蛋白质组学鉴定与提高生存相关
5. Human papillomavirus: Trends in human papillomavirus rates, vaccine uptake, and factors driving intention to vaccinate. [D] . Wilson, Andrew. 2015

机译：人乳头瘤病毒：人乳头瘤病毒的发生率，疫苗摄入量和驱动疫苗接种意向的趋势。
6. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5) versus podophyllotoxin cream (0.15) in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial) [O] . Macey L. Murray, Jade Meadows, Caroline J. Doré, 2018

机译：人乳头瘤病毒感染：咪喹莫特乳膏（5％）与鬼臼毒素乳膏（0.15％）联合四价人乳头瘤病毒或对照疫苗治疗和预防肛门生殖器疣复发的随机对照试验方案（HIPvac试验）
7. Oral Human Papillomavirus Infection Before and After Treatment for Human Papillomavirus 16–Positive and Human Papillomavirus 16–Negative Head and Neck Squamous Cell Carcinoma [O] . Yuri Agrawal, Wayne M. Koch, Weihong Xiao, 2008

机译：口服人乳头瘤病毒治疗前后人乳头瘤病毒16-阳性和人乳头瘤病毒16阴性头颈鳞状细胞癌

Human Papillomavirus Vaccine: A New Opportunity for the Treatment of Human Papillomavirus Infections

摘要

著录项

相似文献

相关主题

期刊订阅